LGALS9 and dengue disease: Our group was the first to demonstrate the dynamic release of Gal-9 in acute DENV infection [3]; plasma levels of Gal-9 were significantly elevated in patients during the critical phase of acute DENV infection compared with those in patients suffering from a non-dengue febrile illness or healthy control subjects (Table 1), and these levels were significantly decreased during the recovery phase.